Seeking Alpha · 1 min read

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:

Read full article at Seeking Alpha

More Startup & VC News